Lifecore Biomedical, Inc. De (LFCR) Share-based Compensation (2010 - 2025)

Lifecore Biomedical's Share-based Compensation history runs 16 years deep, the most recent figure standing at $1.8 million for Q2 2025.

• In Q2 2025, Share-based Compensation rose 13.58% year-over-year to $1.8 million; the TTM figure through May 2025 stood at $10.2 million (up 63.81% YoY), while the FY2025 annual figure was $10.2 million, up 63.81% from the prior year.
• Share-based Compensation was $1.8 million for Q2 2025 at Lifecore Biomedical, down from $2.6 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $3.4 million in Q4 2024 to a low of $620000.0 in Q3 2021.
• Historically, Share-based Compensation has averaged $1.3 million across 5 years, with a median of $1.0 million in 2022.
• The sharpest annual moves came in 2021 and 2024: Share-based Compensation tumbled 30.49% in 2021, then surged 113.82% in 2024.
• A 5-year view of Share-based Compensation shows it stood at $686000.0 in 2021, then surged by 61.52% to $1.1 million in 2022, then jumped by 42.33% to $1.6 million in 2023, then surged by 113.82% to $3.4 million in 2024, then sank by 46.17% to $1.8 million in 2025.
• The last three Share-based Compensation figures came in at $1.8 million (Q2 2025), $2.6 million (Q1 2025), and $3.4 million (Q4 2024), per Business Quant data.